ENTITY
Nanxin Pharmaceutical
Nanxin Pharmaceutical
PulseAugur coverage of Nanxin Pharmaceutical — every cluster mentioning Nanxin Pharmaceutical across labs, papers, and developer communities, ranked by signal.
Total · 30d
0
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
- 2026-06-09 regulatory Nanxin Pharmaceutical was fined 11.5 million yuan for information disclosure violations and will have risk warnings applied to its stock. source
RECENT · PAGE 1/1 · 2 TOTAL
-
Nanxin Pharma fined 11.5M yuan for disclosure violations; U.S. Steel invests $2.5B
Nanxin Pharmaceutical has received an administrative penalty from the Hunan Securities Regulatory Bureau for alleged information disclosure violations. The company and its personnel face a total fine of 11.5 million yua…
-
Nanxin Pharmaceutical's controlling shareholder plans strategic restructuring
Nanxin Pharmaceutical announced that its controlling shareholder, Yifa Investment Group, is undergoing a strategic restructuring. The details of this restructuring are still being determined, but it is not expected to a…